Bull
$4.60
Scenario price
$2.880
-0.106 (-3.68%)At close
Community Health Systems, Inc. is a healthcare company. The Company's affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 32 distinct markets across 12 states. Its subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses.
Community Health Systems Inc (CYH) is currently priced at $2.88, which is below the average analyst price target of $3, indicating a potential upside of about 4.17%. However, the company has a forward P/E ratio of 17.61, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 49.24 indicates that the stock is neither overbought nor oversold, which suggests a neutral sentiment. The main risk is the company's significant debt, which stands at $9.578 billion, coupled with a negative net income of $58 million in Q1 2026, reflecting ongoing profitability challenges. Therefore, while there is some upside potential, the risks associated with financial performance and debt levels warrant a cautious approach.
BMO Capital
$3
2026-09-22
BMO Capital
2026-09-22
Price Target
$3
Truist
—
2026-07-27
Truist
2026-07-27
Price Target
—
UBS
$3
2026-07-24
UBS
2026-07-24
Price Target
$3
Barclays
$3
2026-07-23
Barclays
2026-07-23
Price Target
$3
Truist
$3
2026-07-14
Truist
2026-07-14
Price Target
$3
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Community Health Systems Schedules Q3 2026 Conference Call

BMO Capital Initiates Coverage on Community Health Systems

Community Health Systems to Participate in Healthcare Conference

Community Health Systems to Participate in Healthcare Conference

Community Health Systems Q2 2026 Earnings Call Insights
Community Health Systems, Inc. is a healthcare company. The Company's affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 32 distinct markets across 12 states. Its subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).
Community Health Systems Inc (CYH) is currently priced at $2.88, which is below the average analyst price target of $3, indicating a potential upside of about 4.17%. However, the company has a forward P/E ratio of 17.61, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 49.24 indicates that the stock is neither overbought nor oversold, which suggests a neutral sentiment. The main risk is the company's significant debt, which stands at $9.578 billion, coupled with a negative net income of $58 million in Q1 2026, reflecting ongoing profitability challenges. Therefore, while there is some upside potential, the risks associated with financial performance and debt levels warrant a cautious approach.
18 analysts cover CYH: 1 rate it Buy, 12 Hold and 5 Sell. The average price target is 3.67.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.